ALIGN TECHNOLOGY, INC. Revenue
ALIGN TECHNOLOGY, INC. (ALGN) reported Revenue of $1.06 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $1.06B, a 4.32% increase year-over-year.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $1.04B, a 6.21% increase year-over-year.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $1.05B, a 5.26% increase year-over-year.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $995.69M, a 1.82% increase year-over-year.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $4.03B, a 0.90% increase from fiscal 2024.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $4.00B, a 3.54% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $3.86B, a 3.42% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $3.73B, a 5.51% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.06B 10-Q · filed 2026-08-05 | $2.10B 10-Q · filed 2026-08-05 | $3.14B derived: sum of 3 quarters · filed 2026-08-05 | $4.14B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.04B 10-Q · filed 2026-05-06 | $2.09B derived: sum of 2 quarters · filed 2026-05-06 | $3.08B derived: sum of 3 quarters · filed 2026-05-06 | $4.10B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.05B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.04B derived: sum of 2 quarters · filed 2026-02-27 | $3.06B derived: sum of 3 quarters · filed 2026-08-05 | $4.03B 10-K · filed 2026-02-27 |
| 2025-09-30 | $995.69M 10-Q · filed 2025-11-05 | $2.01B derived: sum of 2 quarters · filed 2026-08-05 | $2.99B 10-Q · filed 2025-11-05 | $3.98B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.01B 10-Q · filed 2026-08-05 | $1.99B 10-Q · filed 2026-08-05 | $2.99B derived: sum of 3 quarters · filed 2026-08-05 | $3.96B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $979.26M 10-Q · filed 2026-05-06 | $1.97B derived: sum of 2 quarters · filed 2026-05-06 | $2.95B derived: sum of 3 quarters · filed 2026-05-06 | $3.98B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $995.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.97B derived: sum of 2 quarters · filed 2026-02-27 | $3.00B derived: sum of 3 quarters · filed 2026-02-27 | $4.00B 10-K · filed 2026-02-27 |
| 2024-09-30 | $977.87M 10-Q · filed 2025-11-05 | $2.01B derived: sum of 2 quarters · filed 2025-11-05 | $3.00B 10-Q · filed 2025-11-05 | $3.96B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.03B 10-Q · filed 2025-08-06 | $2.03B 10-Q · filed 2025-08-06 | $2.98B derived: sum of 3 quarters · filed 2026-02-27 | $3.94B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $997.43M 10-Q · filed 2025-05-08 | $1.95B derived: sum of 2 quarters · filed 2026-02-27 | $2.91B derived: sum of 3 quarters · filed 2026-02-27 | $3.92B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $956.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.92B derived: sum of 2 quarters · filed 2026-02-27 | $2.92B derived: sum of 3 quarters · filed 2026-02-27 | $3.86B 10-K · filed 2026-02-27 |
| 2023-09-30 | $960.21M 10-Q · filed 2024-11-05 | $1.96B derived: sum of 2 quarters · filed 2024-11-05 | $2.91B 10-Q · filed 2024-11-05 | $3.81B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.00B 10-Q · filed 2024-08-02 | $1.95B 10-Q · filed 2024-08-02 | $2.85B derived: sum of 3 quarters · filed 2025-02-28 | $3.74B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $943.15M 10-Q · filed 2024-05-03 | $1.84B derived: sum of 2 quarters · filed 2025-02-28 | $2.74B derived: sum of 3 quarters · filed 2025-02-28 | $3.70B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $901.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.79B derived: sum of 2 quarters · filed 2025-02-28 | $2.76B derived: sum of 3 quarters · filed 2025-02-28 | $3.73B 10-K · filed 2025-02-28 |
| 2022-09-30 | $890.35M 10-Q · filed 2023-11-03 | $1.86B derived: sum of 2 quarters · filed 2023-11-03 | $2.83B 10-Q · filed 2023-11-03 | $3.86B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $969.55M 10-Q · filed 2023-08-04 | $1.94B 10-Q · filed 2023-08-04 | $2.97B derived: sum of 3 quarters · filed 2024-02-28 | $3.99B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $973.22M 10-Q · filed 2023-05-05 | $2.00B derived: sum of 2 quarters · filed 2024-02-28 | $3.02B derived: sum of 3 quarters · filed 2024-02-28 | $4.03B derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.05B derived: sum of 2 quarters · filed 2024-02-28 | $3.06B derived: sum of 3 quarters · filed 2024-02-28 | $3.95B 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.02B 10-Q · filed 2022-11-04 | $2.03B derived: sum of 2 quarters · filed 2022-11-04 | $2.92B 10-Q · filed 2022-11-04 | $3.76B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $1.01B 10-Q · filed 2022-08-04 | $1.91B 10-Q · filed 2022-08-04 | $2.74B derived: sum of 3 quarters · filed 2023-02-27 | $3.47B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $894.77M 10-Q · filed 2022-05-05 | $1.73B derived: sum of 2 quarters · filed 2023-02-27 | $2.46B derived: sum of 3 quarters · filed 2023-02-27 | $2.82B derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $834.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.57B derived: sum of 2 quarters · filed 2023-02-27 | $1.92B derived: sum of 3 quarters · filed 2023-02-27 | $2.47B 10-K · filed 2023-02-27 |
| 2020-09-30 | $734.14M 10-Q · filed 2021-11-02 | $1.09B derived: sum of 2 quarters · filed 2021-11-02 | $1.64B 10-Q · filed 2021-11-02 | $2.29B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $352.31M 10-Q · filed 2021-08-04 | $903.28M 10-Q · filed 2021-08-04 | $1.55B derived: sum of 3 quarters · filed 2022-02-25 | $2.16B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $550.96M 10-Q · filed 2021-05-05 | $1.20B derived: sum of 2 quarters · filed 2022-02-25 | $1.81B derived: sum of 3 quarters · filed 2022-02-25 | $2.41B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $649.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.26B derived: sum of 2 quarters · filed 2022-02-25 | $1.86B derived: sum of 3 quarters · filed 2022-02-25 | $2.41B 10-K · filed 2022-02-25 |
| 2019-09-30 | $607.34M 10-Q · filed 2020-10-30 | $1.21B derived: sum of 2 quarters · filed 2020-10-30 | $1.76B 10-Q · filed 2020-10-30 | $2.29B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $600.70M 10-Q · filed 2020-07-31 | $1.15B 10-Q · filed 2020-07-31 | $1.68B derived: sum of 3 quarters · filed 2021-02-26 | $2.19B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $548.97M 10-Q · filed 2020-05-05 | $1.08B derived: sum of 2 quarters · filed 2021-02-26 | $1.59B derived: sum of 3 quarters · filed 2021-02-26 | $2.08B derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $534.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.04B derived: sum of 2 quarters · filed 2021-02-26 | $1.53B derived: sum of 3 quarters · filed 2021-02-26 | $1.97B 10-K · filed 2021-02-26 |
| 2018-09-30 | $505.29M 10-Q · filed 2019-10-31 | $995.55M derived: sum of 2 quarters · filed 2019-10-31 | $1.43B 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $490.26M 10-Q · filed 2019-08-01 | $927.18M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $436.92M 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $1.47B 10-K · filed 2020-02-28 | |||
| 2016-12-31 | $1.08B 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |